Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Effector Therapeutics
Special Reports
The 2024 Biotech Graveyard
Beware: ghosts of biotech’s past.
Gabrielle Masson
Oct 31, 2024 5:00am
MBX Biosciences, MaaT Pharma and more—Chutes & Ladders
Jun 28, 2024 8:30am
The end of eFFECTOR Therapeutics: Oncology biotech winds down
Jun 24, 2024 10:19am
Moderna promotes Andres to new strategy role—Chutes & Ladders
Sep 30, 2022 9:30am
J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders
Aug 12, 2022 9:30am
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Oct 13, 2021 8:40am
